SecondWave Systems raises $7M Series A to Accelerate Clinical Development of a Novel Ultrasound-Based Anti-Inflammatory Therapy

SecondWave Systems完成700万美元A轮融资，以加速推进一种新型超声波抗炎疗法的临床开发。

ST. PAUL, Minn., April 8, 2025-- SecondWave Systems, Inc., a clinical stage medical device company developing a novel ultrasound-based treatment for inflammatory disorders, announced today that it has closed a $7M Series A financing round. The financing was led by Treo Ventures and a major healthcare strategic, with participation from Scientific Health Development and the University of Minnesota's Discovery Capital and SSBCI funds.

明尼苏达州圣保罗，2025年4月8日——SecondWave Systems, Inc.是一家临床阶段的医疗设备公司，致力于开发一种基于超声波的新型炎症性疾病治疗方法。该公司今天宣布已完成700万美元的A轮融资。本轮融资由Treo Ventures和一家大型医疗保健战略投资者领投，Scientific Health Development、明尼苏达大学的Discovery Capital基金及SSBCI基金参与了投资。

Proceeds from the financing will support SecondWave's next clinical study, leveraging the success of their first-in-human study that demonstrated a significant reduction in rheumatoid arthritis disease activity..

融资所得将支持SecondWave的下一阶段临床研究，利用其首次人体研究的成功经验，该研究显示类风湿关节炎疾病活动显著减少。

The new financing builds on prior funding from U.S. government partners, including the Defense Advanced Research Projects Agency (DARPA) and the Advanced Research Projects Agency for Health (ARPA-H), which supported prior research and the development of the SecondWave MINI™, a first-of-its-kind, noninvasive, wearable therapeutic ultrasound device intended for treatment of inflammatory diseases..

新的融资建立在美国政府合作伙伴之前的资助基础上，包括美国国防高级研究计划局 (DARPA) 和美国卫生高级研究计划局 (ARPA-H)，这些机构支持了先前的研究以及 SecondWave MINI™ 的开发。这是一种首创的、非侵入性的、可穿戴的治疗超声波设备，旨在用于治疗炎症性疾病。

'As we work to develop and commercialize the SecondWave MINI as a new class of noninvasive therapy, we are very excited to enter the next phase of development with a strong set of new investor partners,' said SecondWave CEO Anuj Bhardwaj. 'Our team at SecondWave is dedicated to improving patient quality of life for millions of Americans who suffer from chronic inflammatory disorders.'.

“在我们努力开发并将SecondWave MINI作为一类新型非侵入性疗法进行商业化的过程中，我们非常高兴能与一批新的强大投资者伙伴一起进入发展的下一阶段，” SecondWave首席执行官Anuj Bhardwaj表示。“我们在SecondWave的团队致力于改善数百万患有慢性炎症性疾病的美国患者的生活质量。”

'We are enthusiastic to partner with SecondWave's experienced team to advance a novel and highly differentiated therapy that will positively impact the lives of countless patients while reducing the cost of care,' said Mudit K. Jain, PhD, General Partner, Treo Ventures.

“我们非常高兴能与SecondWave经验丰富的团队合作，推进一种新颖且高度差异化的疗法，这将对无数患者的生活产生积极影响，同时降低护理成本，”Treo Ventures的普通合伙人Mudit K. Jain博士表示。

SecondWave advisory board member Paul Peter Tak, MD, PhD, a biotech leader and physician-scientist who was pivotal in elucidating the role of bioelectronic medicine as a therapeutic approach for autoimmune diseases, further stated, 'as one of the early innovators demonstrating how implanted vagus nerve stimulation can treat rheumatoid arthritis, I am excited by the potential for widespread adoption of SecondWave's novel approach of using noninvasive ultrasound therapy to treat immune-mediated inflammatory conditions.' .

SecondWave顾问委员会成员、生物技术领袖及医生科学家Paul Peter Tak医学博士、哲学博士曾对阐明生物电子医学作为自身免疫性疾病治疗方法的作用至关重要，他进一步表示：“作为早期证明植入式迷走神经刺激可以治疗类风湿性关节炎的创新者之一，我对SecondWave使用非侵入性超声波疗法治疗免疫介导炎症疾病的新型方法得到广泛采用的潜力感到兴奋。”

For more information on SecondWave Systems, visit www.secondwaveUS.com.

有关 SecondWave Systems 的更多信息，请访问 www.secondwaveUS.com。

About SecondWave Systems, Inc.

关于SecondWave Systems公司

SecondWave Systems is revolutionizing treatment of inflammatory disease. The company is developing a first-of-its-kind noninvasive, wearable, and personalized ultrasound stimulation platform that will give patients and their physicians a new option for treating debilitating or life-threatening disease.

SecondWave Systems 正在革新炎症性疾病的治疗方法。该公司正在开发一种首创的非侵入式、可穿戴且个性化的超声波刺激平台，将为患者及其医生提供一种治疗致残或危及生命的疾病的新选择。

The company's SecondWave MINI™ device uses proprietary low-intensity focused ultrasound technology to stimulate the spleen with the goal of treating acute and chronic inflammation disorders. This technology is being investigated in clinical studies to treat multiple inflammatory conditions including rheumatoid arthritis.

该公司的一款名为 SecondWave MINI™ 的设备使用了其专有的低强度聚焦超声波技术来刺激脾脏，目标是治疗急性和慢性炎症性疾病。该技术正在临床研究中被用于治疗多种炎症性疾病，包括类风湿性关节炎。

For more information, visit www.secondwaveUS.com..

欲了解更多信息，请访问 www.secondwaveUS.com。

Contact:

联系人：

Media Contact

媒体联系人

info@secondwaveUS.com

info@secondwaveUS.com